back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-30 11:14 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1 vol |
1 | |
| Filed 2025-07-30 11:13 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $0.05 each |
$20 | |
| Filed 2025-07-30 11:11 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $1,000 each |
||
| Filed 2025-07-30 11:11 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1 vol |
||
| Filed 2025-07-30 10:44 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1 vol |
||
| Filed 2025-07-30 10:44 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1 vol |
1 | |
| Filed 2025-07-30 10:42 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $1,000 each |
$20 | |
| Filed 2025-07-30 10:42 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $1,000 each |
||
| Filed 2025-07-28 12:34 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+20 vol |
||
| Filed 2025-07-28 12:34 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+20 vol |
||
| Filed 2025-07-28 12:11 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $1,000 each |
||
| Filed 2025-07-28 12:11 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $1,000 each |
||
| Filed 2025-07-28 12:34 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+20 vol |
20 | |
| Filed 2025-07-28 12:12 Tx date 2023-07-31 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-28 12:11 Tx date 2025-07-25 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $1,000 each |
$20 | |
| Filed 2025-07-28 11:54 Tx date 2023-07-31 |
$N/A
Unbuzzd Wellness Inc. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-04-07 15:40 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
15,628 | |
| Filed 2025-04-07 15:40 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-02-07 16:51 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-109,515
-4,900 vol $22.35 each |
436 | |
| Filed 2025-02-07 16:51 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
5,336 | |
| Filed 2025-02-07 16:50 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
7,936 | |
| Filed 2025-02-07 16:50 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
0 | |
| Filed 2025-02-07 16:49 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:48 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:47 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:39 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:38 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:37 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:37 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-109,515
-4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:36 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:36 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$59,098
+2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:11 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:11 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-109,515
-4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:10 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$59,098
+2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:09 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2024-10-01 13:21 Tx date 2024-09-26 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$39,375
+7,500 vol $5.25 each |
7,500 | |
| Filed 2024-09-03 18:49 Tx date 2023-01-27 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
||
| Filed 2024-09-03 18:48 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-7,692 vol |
||
| Filed 2024-08-27 15:37 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-7,692 vol |
||
| Filed 2023-01-31 18:23 Tx date 2023-01-27 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
||
| Filed 2024-08-27 17:24 Tx date 2024-08-15 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Kotra Trust (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-40,566 vol |
634 | |
| Filed 2024-08-27 17:23 Tx date 2024-08-15 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-851,889 vol |
13,311 | |
| Filed 2024-08-27 17:20 Tx date 2024-08-15 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-507,861 vol |
7,936 | |
| Filed 2024-08-27 17:16 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-507,861 vol |
||
| Filed 2024-08-27 17:16 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-851,889 vol |
||
| Filed 2024-08-27 17:16 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Kotra Trust (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-40,566 vol |
||
| Filed 2024-08-27 15:46 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+7,692 vol |
7,692 | |
| Filed 2024-08-27 15:37 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-7,692 vol |
492,308 | |
| Filed 2024-08-27 15:32 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Kotra Trust (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-40,566 vol |
634 | |
| Filed 2024-08-27 15:32 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Kotra Trust (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-40,566 vol |
||
| Filed 2024-08-27 15:31 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-851,889 vol |
13,311 | |
| Filed 2024-08-27 15:31 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-851,889 vol |
||
| Filed 2024-08-27 15:28 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-507,861 vol |
7,936 | |
| Filed 2024-08-27 15:28 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-507,861 vol |
||
| Filed 2024-08-27 15:20 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Kotra Trust (Indirect Ownership)
|
Subordinate Voting Shares Class B
38 - Redemption, retraction, cancellation, repurchase
|
-40,566 vol |
||
| Filed 2024-08-27 15:20 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Kotra Trust (Indirect Ownership)
|
Subordinate Voting Shares Class B
38 - Redemption, retraction, cancellation, repurchase
|
-40,566 vol |
||
| Filed 2024-08-27 15:20 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
38 - Redemption, retraction, cancellation, repurchase
|
-851,889 vol |
||
| Filed 2024-08-27 15:20 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
38 - Redemption, retraction, cancellation, repurchase
|
-851,889 vol |
||
| Filed 2024-08-27 15:19 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
38 - Redemption, retraction, cancellation, repurchase
|
-507,861 vol |
||
| Filed 2024-08-27 15:19 Tx date 2024-08-23 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
38 - Redemption, retraction, cancellation, repurchase
|
-507,861 vol |
||
| Filed 2023-08-01 23:38 Tx date 2023-07-31 |
$NA
Celly Nutrition Corp. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: FSD Pharma Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+100 vol |
100 | |
| Filed 2023-08-01 23:37 Tx date 2023-07-31 |
$NA
Celly Nutrition Corp. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: FSD Pharma Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-01 23:36 Tx date 2023-07-31 |
$NA
Celly Nutrition Corp. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: FSD Pharma Inc. (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+100,000,000 vol $0.0005 each |
100,000,000 | |
| Filed 2023-08-01 23:35 Tx date 2023-07-31 |
$NA
Celly Nutrition Corp. |
Kotra, Lakshmi
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: FSD Pharma Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-21 12:14 Tx date 2023-02-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$2,390
+1,000 vol $2.39 each |
515,797 | |
| Filed 2023-01-31 18:23 Tx date 2023-01-27 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2023-01-24 19:15 Tx date 2023-01-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-216,797 vol |
0 | |
| Filed 2023-01-24 19:14 Tx date 2023-01-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$242,812
+216,797 vol $1.12 each |
514,797 | |
| Filed 2023-01-19 22:18 Tx date 2023-01-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+216,797 vol |
||
| Filed 2023-01-19 22:17 Tx date 2023-01-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-216,797 vol |
||
| Filed 2023-01-19 22:18 Tx date 2023-01-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+216,797 vol |
514,797 | |
| Filed 2023-01-19 22:17 Tx date 2023-01-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-216,797 vol |
0 | |
| Filed 2022-04-19 15:27 Tx date 2022-04-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+216,797 vol |
216,797 | |
| Filed 2022-04-19 15:25 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-19 15:24 Tx date 2022-04-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-371,918.25
-165,297 vol $2.25 each |
0 | |
| Filed 2022-04-19 15:23 Tx date 2022-04-06 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-87,504.10
-51,473 vol $1.70 each |
0 | |
| Filed 2021-12-27 15:58 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
51,473 | ||
| Filed 2021-12-27 15:57 Tx date 2021-11-15 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+165,297 vol |
165,297 | |
| Filed 2021-12-27 15:50 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-24 10:58 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-23 13:49 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: ILace Therapeutics International, Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
865,200 | ||
| Filed 2021-12-23 13:48 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Kotra Trust (Indirect Ownership)
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
41,200 | ||
| Filed 2021-12-23 13:46 Tx date 2021-12-07 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$7,500
+5,000 vol $1.50 each |
298,000 | |
| Filed 2021-12-23 13:45 Tx date 2021-11-05 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$8,004
+4,600 vol $1.74 each |
293,000 | |
| Filed 2021-12-23 13:44 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
288,400 | ||
| Filed 2021-09-24 10:58 Tx date 2021-09-21 |
$HUGE
FSD Pharma Inc. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
51,500 |